Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

Discover how businesses support global water goals, reducing risks and restoring ecosystems with the Freshwater Challenge by 2030.

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...

When combined with seasonal malaria chemoprevention, the vaccine RTS,S has shown up to 75 per cent efficacy in preventing ...

Bharat Biotech and GSK announce price reduction for the world’s first malaria vaccine to under $5. This move aims to improve ...